How H1 Create A Healthier Future
H1 provides a health data platform to support the end-to-end therapeutic development process of medical companies and healthcare systems. The company was founded in 2017 and is based in New York, USA. They provide a trusted and single source of truth for healthcare professional information. H1 Connect houses a world of information, the solutions it fuels allow customers to drill into the HCPs, treatment areas, geographies, or localized areas most relevant to them easily.
There are users from almost 84 countries throughout the globe. Not only that 50% of the top global pharma accounts trust H1. They have 5 offices globally and raised almost $171M. They try to go above and beyond to do what is right for the user and make sure to put company objectives above the team or personal objectives. There are almost 15 investors including dRx capital, Lead Edge Capital, Menlo ventures, Flex capital, Y combinator, lux capital etc. Their top customers Horizon, Baxter, UCSF, and Novartis.
H1 is the connecting force for global HCP, clinical, scientific, and research information.
The H1 Connect platform democratizes access to HCP knowledge and groundbreaking insights for life sciences, academic medical institutions, health systems, and payors. It Connects fuels a robust product suite that helps customers discover and engage industry experts, drive equitable research, access groundbreaking science, and accelerate commercial success with the most robust and accurate healthcare professional data. It has allowed its users to gather important data sources all in one system, 400 hours were drastically reduced to 40 hours.
H1 rolled out its trial landscape feature, to help pharmaceutical companies identify the right sites and physician investigators for a trial. The single source of truth about medical professionals globally. It Identifies and engages healthcare providers from advisory board members, to treatment specialists, digital opinion leaders, and more. It also creates a more informed and equitable clinical trial landscape with access and understanding of diversity, principal investigator profiles, and clinical trial sites for access expansion to therapeutic options for patients.
H1 Precise provides health plans and digital health companies with the most current, actionable and high-quality provider data available.
The company focuses on data that is unique, accessible, agile, purpose-built, and impactful.
It provides data related to clinical trials which drive progress forward and provide patients with early access to new treatments that lead to better health equity, access to care, and outcomes. It has Accelerated all phases of the sales cycle undertaken by commercial teams. It has been transforming how patients discover, evaluate and engage doctors while helping payors solve provider data accuracy challenges. The company focuses to Create a community where the industry can access the recommendations and opinions of experts and experts can amplify their work to advance the world of medicine and biology.
H1 Connect maintains the most comprehensive, constantly updated datasets - housing 10M+ HCPs, 20K+ institutional profiles, 25M+ peer-reviewed publications, 420K+ clinical trials, 2 billion procedures, 3 billion diagnoses, and over 9M claims globally.
It Connects and combines data science and technology to contextualize and connect disparate sources of information, including claims data, HCP's clinical and scholarly work, published research, and key expert opinions. It also serves as the foundation for a robust portfolio of vertical solutions that are tailored to meet the needs of key customer functions including Medical Affairs, Medical Science Liaisons, Clinical Operations, Feasibility teams, Academic & Research Institutions, Payors, and Digital Health companies. Recently, H1 and Lightship Partner to Accelerate Clinical Studies with Diversity, Equity, and Inclusion Data. According to Ariel Katz, founder, and CEO of H1, “H1’s integration with platforms like Lightship will accelerate and transform how treatments reach patients – and improve the health of all patients across the globe.”
Visit their website to learn more.